Compare Injective (INJ) vs Morpho (MORPHO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Morpho — how do they compare? Injective trades at Rp82,646 (market cap Rp8,24T, Rp935,45M 24h volume), while Morpho trades at Rp34,931 (market cap Rp17,98T, Rp165,4M 24h volume). The key difference: Morpho is far larger — about 2.2× Injective's market cap, and Morpho's supply is capped (516,6M / 1B MORPHO (52%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Morpho for 16 Days on average.
| INJ | MORPHO | |
|---|---|---|
Market Cap | Rp8,24T | Rp17,98T |
Volume (24h) | Rp935,45M | Rp165,4M |
Circulating Supply | 100M INJ | 516,6M / 1B MORPHO (52%) |
Typical Hold Time | 37 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp81,858 with a market cap of Rp8.16 trillion. The technical outlook is bearish, with moving averages indicating selling pressure, while oscillators are neutral. Key support lies at Rp78,560. No major protocol updates or ecosystem news were identified in the latest review. Trading volume and network activity metrics are required for a complete short-term trend assessment.
Overall outlook is cautious due to bearish technical signals. The primary opportunity is a potential rebound from oversold conditions if support holds. Major risks include high volatility, lack of recent fundamental catalysts, and broader crypto market sentiment. Investors should monitor for any new ecosystem developments or shifts in trading volume.
Morpho shows bullish technical momentum with a current price of Rp35,260, trading near resistance levels. The asset maintains strong moving average signals while oscillators remain neutral. With 52% of the max supply in circulation and an average hold time of 16 days, the token demonstrates moderate distribution and holding patterns. No major protocol updates or ecosystem developments were reported recently.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include potential breakout above resistance levels, while risks involve low liquidity and the absence of recent ecosystem developments. Investors should monitor for protocol updates and increased trading volume.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Morpho
Morpho is an open, efficient, and trustless platform designed for earning yield and borrowing assets. Lenders utilize Morpho Vaults to maximize their returns, while borrowers gain access to assets through Morpho Markets. Its permissionless infrastructure empowers developers and businesses to create markets, curate vaults, and build applications. With immutable contracts, isolated lending markets, improved interest rates, and low gas fees, Morpho offers efficiency, flexibility, and a developer-friendly environment.
Read more on MORPHO →
